Literature DB >> 20937987

Selecting a noninvasive imaging study after an inconclusive exercise test.

Ron Blankstein1, Adam D Devore.   

Abstract

Mesh:

Year:  2010        PMID: 20937987     DOI: 10.1161/CIRCULATIONAHA.109.903351

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Yield of downstream tests after exercise treadmill testing: a prospective cohort study.

Authors:  Mitalee P Christman; Marcio Sommer Bittencourt; Edward Hulten; Ekta Saksena; Jon Hainer; Hicham Skali; Raymond Y Kwong; Daniel E Forman; Sharmila Dorbala; Patrick T O'Gara; Marcelo F Di Carli; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2014-02-05       Impact factor: 24.094

2.  Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry.

Authors:  Michael K Cheezum; Prem Srinivas Subramaniyam; Marcio S Bittencourt; Edward A Hulten; Brian B Ghoshhajra; Nishant R Shah; Daniel E Forman; Jon Hainer; Marcia Leavitt; Ram Padmanabhan; Hicham Skali; Sharmila Dorbala; Udo Hoffmann; Suhny Abbara; Marcelo F Di Carli; Henry Gewirtz; Ron Blankstein
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-04-20       Impact factor: 6.875

3.  Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing.

Authors:  Théo Pezel; Thierry Unterseeh; Philippe Garot; Thomas Hovasse; Marine Kinnel; Stéphane Champagne; Solenn Toupin; Francesca Sanguineti; Jérôme Garot
Journal:  J Cardiovasc Magn Reson       Date:  2021-07-05       Impact factor: 5.364

4.  Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists.

Authors:  Marcio S Bittencourt; Mitalee P Christman; Edward Hulten; Sanjay Divakaran; Hicham Skali; Raymond Y Kwong; Jon Hainer; Daniel E Forman; James M Kirshenbaum; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  Am J Cardiol       Date:  2014-05-02       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.